http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102213931-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8487464fa6768affe265413ae02be74c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0684 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0685 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2877d6ce144c86b329f4087cc71a50f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64dac90c45aebea415d9c97dbb24f3e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537d9b340f8a6ef0852d90dbb50a8c92 |
| publicationDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102213931-B1 |
| titleOfInvention | Methods to develop the reconstituted miniature tissues with multiple cell types from patient-derived stem or tumor cells |
| abstract | The present invention relates to a tissue structure mimic and a method of manufacturing the same, which has developed a tumor organoid technology that is used as a platform for developing new drugs and disease models by culturing normal cells and tumor cells in vitro. More specifically, bladder tissue and bladder Stem cells or tumor cells-based multi-cell tissue structure mimetics prepared by culturing tumor cells in vitro and reconstructing microenvironmental cells such as stromal cells, vascular cells, immune cells, and muscle cells based on 3D bioprinting And to a method of manufacturing the same. Stem cells or tumor cells-based multi-cell tissue structure mimetics designed through the present invention are the main elements of the tissue microenvironment, such as stromal cells, vascular cells, immune cells, muscle cells, etc. It has been confirmed that the physiological and pathological characteristics of the cells can be cultivated to be used as a new drug development and disease model platform. More specifically, bladder tissues and bladder tumor tissues can be cultured in vitro to produce new drugs. It is expected to be useful as a development and disease model platform. |
| priorityDate | 2019-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.